Nedira Salzman-Frenkel.
Corporate Officer/Principal en NEUROSENSE THERAPEUTICS LTD. .
Perfil
Nedira Salzman-Frenkel is currently the Vice President-Business Development at Neurosense Therapeutics Ltd.
Previously, she served as the Chief Executive Officer at Radikal Therapeutics, Inc. from 2017 to 2021.
Ms. Salzman-Frenkel holds a graduate degree from The Hebrew University of Jerusalem, an undergraduate degree from Ben-Gurion University of the Negev, and an MBA from Recanati School of Business Administration.
Cargos activos de Nedira Salzman-Frenkel.
| Empresas | Cargo | Inicio |
|---|---|---|
| NEUROSENSE THERAPEUTICS LTD. | Corporate Officer/Principal | 01/03/2022 |
Antiguos cargos conocidos de Nedira Salzman-Frenkel..
| Empresas | Cargo | Fin |
|---|---|---|
Radikal Therapeutics, Inc.
 Radikal Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Radikal Therapeutics, Inc. develops transformative pharmaceuticals of bifunctional edox-based small molecules. The company was founded by Andrew L. Salzman and is headquartered in West Tisbury, MA. | Director Ejecutivo | 01/10/2021 |
Formación de Nedira Salzman-Frenkel..
| The Hebrew University of Jerusalem | Graduate Degree |
| Ben-Gurion University of the Negev | Undergraduate Degree |
| Recanati School of Business Administration | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| NEUROSENSE THERAPEUTICS LTD. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Radikal Therapeutics, Inc.
Radikal Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Radikal Therapeutics, Inc. develops transformative pharmaceuticals of bifunctional edox-based small molecules. The company was founded by Andrew L. Salzman and is headquartered in West Tisbury, MA. | Commercial Services |
- Bolsa de valores
- Insiders
- Nedira Salzman-Frenkel.
